Efficacy, safety, and in-hospital outcomes of subcutaneous versus transvenous implantable defibrillator therapy: A meta-analysis and systematic review
CF Chen, CL Jin, MJ Liu, YZ Xu - Medicine, 2019 - journals.lww.com
Background: Lead-related complication is an important drawback of trans-venous
implantable cardioverter-defibrillators (TV-ICD). The subcutaneous ICD (S-ICD) was …
implantable cardioverter-defibrillators (TV-ICD). The subcutaneous ICD (S-ICD) was …
Opportunities and drawbacks of the subcutaneous defibrillator across different clinical settings
V Russo, M Ciabatti, M Brunacci… - Expert Review of …, 2023 - Taylor & Francis
Introduction The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an
established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a …
established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a …
S‐ICD is effective in preventing sudden death in arrhythmogenic cardiomyopathy athletes during exercise
V Catto, MA Dessanai, E Sommariva… - Pacing and Clinical …, 2019 - Wiley Online Library
Here, we describe the cases of two elite athletes, with a diagnosis of arrhythmogenic
cardiomyopathy (ACM), in which a subcutaneous implantable cardioverter defibrillator (S …
cardiomyopathy (ACM), in which a subcutaneous implantable cardioverter defibrillator (S …
Impact of ultra‐conservative ICD programming in patients with LVADs: avoiding potentially unnecessary tachy‐therapies
A Robinson, V Parikh, MA Jazayeri… - Pacing and Clinical …, 2022 - Wiley Online Library
Background Patients with left ventricular assist devices (LVAD) often tolerate ventricular
arrhythmias (VA). We aim to assess the frequency and outcomes of ICD therapies averted by …
arrhythmias (VA). We aim to assess the frequency and outcomes of ICD therapies averted by …
[PDF][PDF] The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies
The interplay between donor-specific anti-HLA antibodies (HLA-DSA), histology of active
antibody-mediated rejection (aABMRh), transplant glomerulopathy (cg), and graft failure in …
antibody-mediated rejection (aABMRh), transplant glomerulopathy (cg), and graft failure in …